χ-Conotoxin and Tricyclic Antidepressant Interactions at the Norepinephrine Transporter Define a New Transporter Model
about
Designing modulators of monoamine transporters using virtual screening techniquesRole of voltage-gated calcium channels in ascending pain pathwaysSubstrate binding and formation of an occluded state in the leucine transporter.Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter.Monoamine transporters: vulnerable and vital doorkeepers.Monoamine transporter structure, function, dynamics, and drug discovery: a computational perspective.Novel structure--function information on biogenic amine transporters revealed by site-directed mutagenesis and alkylation.Review. The molecular logic of sodium-coupled neurotransmitter transporters.Targeting voltage-gated calcium channels for neuropathic pain management.Future directions for intrathecal pain management: a review and update from the interdisciplinary polyanalgesic consensus conference 2007.Comparative modeling of the human monoamine transporters: similarities in substrate binding.Characterization of [³H]CFT binding to the norepinephrine transporter suggests that binding of CFT and nisoxetine is not mutually exclusive.Biophysical Approaches to the Study of LeuT, a Prokaryotic Homolog of Neurotransmitter Sodium Symporters.Mechanism for cocaine blocking the transport of dopamine: insights from molecular modeling and dynamics simulationsInteraction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket.Structure and Dynamics Study of LeuT Using the Markov State Model and Perturbation Response Scanning Reveals Distinct Ion Induced Conformational States.Overview of Monoamine Transporters.Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters.Cloning, Synthesis and Functional Characterization of a Novel α-Conotoxin Lt1.3.
P2860
Q26781605-C80CC77B-6A00-4219-BF10-B70995533186Q30436560-23A53236-0A71-4FD7-8CAA-B40D31FD80D6Q30481294-DC8F01FF-3F73-44C0-9D8E-BA0EC04C6F4DQ35011459-4B70F2C8-70F1-495D-9835-EFE92790EA69Q35877150-D414656B-8DE5-40BF-BF3A-CB29A896A04AQ36331487-85AB139E-BD69-45F2-AF90-B1D50C9FB8D5Q36984682-7D203470-1978-41FD-9ADE-0E65B5CA1EE8Q37314895-4C781DA1-7298-4B9C-B8F4-E86B7DE826BEQ37605352-D01B63A9-1FA9-4885-B81B-5823DFE379C1Q37965890-CAA003C9-F822-42C6-B69E-C1C32FE843DCQ39192034-3B43F424-993B-442C-BB1E-B3DFA9B4EF83Q39293366-A581020D-F9AF-4863-B487-3739431816D1Q39809302-FC4C217B-0545-4062-BB79-0C43F393AD18Q39938422-3C65A8E6-D0A9-4781-9E5B-B8A0482C1796Q42425044-6E730C27-9A15-4978-853F-9DE2A2866061Q45329990-A6FBD626-0CDB-4518-89D5-5B90679D4FC0Q47271566-89C7CB9C-5895-4B2D-BD91-679F8A607306Q48102516-F2C97CF0-4D77-434C-AE13-2393F0DE5548Q52609713-A676198F-4CE5-4593-9F05-20BAD3D37C5D
P2860
χ-Conotoxin and Tricyclic Antidepressant Interactions at the Norepinephrine Transporter Define a New Transporter Model
description
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
im April 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in Journal of Biological Chemistry
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2007
@uk
name
χ-Conotoxin and Tricyclic Anti ...... Define a New Transporter Model
@en
χ-Conotoxin and Tricyclic Anti ...... Define a New Transporter Model
@nl
type
label
χ-Conotoxin and Tricyclic Anti ...... Define a New Transporter Model
@en
χ-Conotoxin and Tricyclic Anti ...... Define a New Transporter Model
@nl
prefLabel
χ-Conotoxin and Tricyclic Anti ...... Define a New Transporter Model
@en
χ-Conotoxin and Tricyclic Anti ...... Define a New Transporter Model
@nl
P2860
P356
P1476
chi-Conotoxin and tricyclic an ...... define a new transporter model
@en
P2093
Filip A Paczkowski
Iain A Sharpe
P2860
P304
17837-17844
P356
10.1074/JBC.M610813200
P407
P577
2007-04-11T00:00:00Z